Fermenta gets FSSAI nod for plant-based Vitamin D3, targets supply ramp-up
Fermenta Biotech has secured FSSAI approval for Vitadee Green, its plant-based Vitamin D3 ingredient, for use in foods, health supplements and nutraceuticals. The company plans to scale India and overseas supply over the next three months.
What happened
Fermenta Biotech received FSSAI approval for plant-based Vitamin D3, Vitadee Green, enabling use in foods, health supplements and nutraceuticals. The company
Key facts
- Over 70% of Fermenta's revenue comes from Vitamin D sales
- ₹551 crore total revenue for year ended March 2026
- Research began in 2014
- Reverse merger in 2017-18
- Ramp-up planned over the next three months
Why this matters
Vitadee Green’s clearance creates opportunities for Fermenta to pursue co-development, distribution and supply partnerships with food, supplement and nutraceutical brands seeking plant-based ingredient claims.
What to watch
- Named customer launches featuring Vitadee Green or plant-based Vitamin D3 claims.
- Evidence of Fermenta capacity additions, export registrations, distributor appointments or multi-year supply contracts.
- Pricing spread between plant-based and lanolin-derived Vitamin D3 ingredients.
- Competing FSSAI approvals for vegan or algae/lichen-derived Vitamin D3.
- Growth in India’s fortified food, vegan nutrition and gummy supplement categories.
- Any regulatory clarification on permitted dosage, food-category usage or labeling claims for plant-based Vitamin D3.
- Secure long-term supply agreements with Indian supplement and fortified-food manufacturers before competitors introduce comparable vegan D3 ingredients.
- Position Vitadee Green around vegan, plant-based, non-animal-origin and export-compliance claims, supported by formulation and stability data.
- Target high-growth formats including gummies, chewables, sachets, functional beverages, infant nutrition and dairy alternatives.
- Use the India approval as a reference point for overseas regulatory filings and distributor partnerships in markets with strong vegan supplement demand.
- Manage price architecture by offering differentiated grades or blends that narrow the cost gap against conventional Vitamin D3.